Andrew Oliver

Andrew is a partner in Moses & Singer LLP's Corporate/M&A practice group, where he advises corporate clients across diverse industries in the structuring, negotiation and execution of sophisticated transactions, corporate and commercial matters, and fiduciary and agency transactions.

Andrew regularly represents buyers and sellers in corporate mergers, acquisitions and dispositions, as well as venture and strategic investors in start-up and early stage financings. He serves as outside legal counsel for numerous clients, from established industry-leading firms to start-up and emerging companies. Andrew provides his clients with timely and trusted guidance regarding a broad range of routine and extraordinary matters, including company formation and financing, internal structuring and governance, shareholder and partnership agreements, corporate trust and agency matters, joint ventures, executive and employee compensation, separations and severance agreements, and general business matters and commercial contracts.

Andrew is also a member of Moses & Singer LLP's Healthcare and Life Sciences group, through which he has developed expertise in counseling life sciences entrepreneurs in connection with entity formation, equity and non-dilutive financing, intellectual property matters, strategic opportunities and general business and legal issues. Andrew spearheaded Moses & Singer's sponsorship of the ELabNYC Bio & Health Entrepreneurship Lab NYC and has worked closely since ELabNYC Inception with Its participant innovators and staff to help foster New York's Emergence as a leader in life sciences entrepreneurship and innovation.

Representative Matters

• Represent a worldwide communications, branding and media company in numerous strategic acquisitions of independent digital, marketing, media, communications and advertising agencies in North America.
• Represented family office in secondary sales of over $1 billion of limited partnership interests in leading private equity funds to various purchasers.
• Represent U.S. division of worldwide trading company in strategic and financial investments in private companies and ventures across multiple industries, including healthcare and green technologies.
• Represent independent advertising, public relations and communications agencies in acquisitions by leading worldwide advertising holding companies.
• Represent worldwide automotive and industrial products manufacturer and distributor in connection with strategic M&A transactions.

Related News

• Moses & Singer Represents Topaz Lighting Corp. in Acquisition by Southwire Company December 14, 2021
• Moses & Singer Represents Tolsa Group in Acquisition of US Bentonite Assets January 21, 2015
• Moses & Singer Represents Key Management in $30 Million Sale of LI Company August 5, 2014
• Moses & Singer Closes $150 Million Sale of Apple & Eve, LLC July 31, 2014
• Moses & Singer LLP Contributes to Lexis Practice Advisor, a LexisNexis Product for Attorneys Handling Transactional Matters January 31, 2013
• Students Benefit from Moses & Singer Mock Interviews April 9, 2012
• Moses & Singer Lawyers Contribute to Lexis® Practice Advisor February 21, 2012
• Moses & Singer Client American Medical Alert Signs Acquisition Agreement with Tunstall September 22, 2011
• Moses & Singer Assists Mitsui in Joint Venture June 24, 2011
• Andrew Oliver Gives His Time and Expertise to Bronx High Schoolers April 11, 2011

Related Events

• Pilot Health Tech NYC May 6, 2014

Related Articles

• Potential Traps for the Unwary: Significant Contractual Provisions That Parties Should Be Aware Of In Light Of COVID-19 March 25, 2020
• Trustees Post-Bankruptcy Counsel Fees not Allowed as Part of its Unsecured Claim against the Bankruptcy Estate January 26, 2016
• New "Tax-Free NY" Program May Entice Businesses to SUNY Campuses May 2013
• The JOBS Act: New Avenues for Raising Capital April 2012